![]() |
市場調査レポート
商品コード
1758586
血液型検査の市場規模・シェア・成長分析 (製品別、検査の種類別、手法別、技術別、用途別、エンドユーザー別、地域別):産業予測 (2025~2032年)Blood Group Typing Market Size, Share, and Growth Analysis, By Product, By Test Type, By Technique, By Technology, By Application, By End User, By Region - Industry Forecast 2025-2032 |
||||||
|
血液型検査の市場規模・シェア・成長分析 (製品別、検査の種類別、手法別、技術別、用途別、エンドユーザー別、地域別):産業予測 (2025~2032年) |
出版日: 2025年06月20日
発行: SkyQuest
ページ情報: 英文 196 Pages
納期: 3~5営業日
|
世界の血液型検査の市場規模は2023年に18億9,000万米ドルと評価され、予測期間(2025-2032年)のCAGRは9.1%で、2024年の20億6,000万米ドルから2032年には41億4,000万米ドルに成長する見通しです。
世界の血液型検査市場は、技術進歩、輸血需要の増加、啓発活動の活発化によって推進されています。頻繁な輸血を必要とするがんや貧血のような慢性疾患の蔓延は、正確な血液型判定の必要性を著しく高めています。PCR、マイクロアレイ、超並列シーケンシングなどの革新的技術は、血液型判定プロセスの効率と精度を高めています。さらに、先進国市場と新興国市場の両方における医療施設の拡大が、サービス需要をさらに促進しています。しかし、高コスト、不十分なインフラ、倫理的懸念などの課題が、2032年までの市場成長を阻害する可能性があります。血液型判定におけるAIと自動化の継続的な統合は、診断精度と納期を改善する有望な手段です。
Global Blood Group Typing Market size was valued at USD 1.89 billion in 2023 and is poised to grow from USD 2.06 billion in 2024 to USD 4.14 billion by 2032, growing at a CAGR of 9.1% during the forecast period (2025-2032).
The global blood group typing market is being propelled by technological advancements, rising demand for blood transfusions, and increasing awareness initiatives. The prevalence of chronic diseases like cancer and anemia, which necessitate frequent transfusions, is significantly boosting the need for accurate blood typing. Innovative techniques such as PCR, microarray, and massively parallel sequencing are enhancing the efficiency and accuracy of blood typing processes. Additionally, the expansion of healthcare facilities across both developed and emerging markets is further driving service demand. However, challenges such as high costs, inadequate infrastructure, and ethical concerns may hinder market growth through 2032. The ongoing integration of AI and automation in blood typing holds promise for improving diagnostic precision and turnaround times moving forward.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Group Typing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Blood Group Typing Market Segments Analysis
Global Blood Group Typing Market is segmented by Product, Test Type, Technique, Technology, Application, End User and region. Based on Product, the market is segmented into Consumables, Instruments and Services & Software. Based on Test Type, the market is segmented into ABO Blood Tests & Rh Typing, Antibody Screening, HLA Typing, Cross-matching Tests and Antigen Typing. Based on Technique, the market is segmented into Assay-based Techniques, PCR-based and Microarray Techniques, Massively Parallel Sequencing and Other Techniques. Based on Technology, the market is segmented into Molecular Typing, Serological Typing, Microarray-based Typing and Next-generation Sequencing. Based on Application, the market is segmented into Blood transfusions, Organ transplants and Diagnostic testing. Based on End User, the market is segmented into Hospitals, Blood Banks, Clinical Laboratories and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Blood Group Typing Market
Globally, governments are enacting policies and programs aimed at encouraging blood donation and enhancing the safety of blood transfusions. Such initiatives play a crucial role in improving the outlook of the blood group typing market by raising awareness and making blood typing services more accessible. Moreover, public health campaigns and subsidies for blood typing equipment are facilitating healthcare facilities' adoption of modern blood typing technologies. As a result, the market is poised for growth as these supportive measures continue to foster a culture of safety and accessibility in blood donation and transfusion practices worldwide.
Restraints in the Global Blood Group Typing Market
A notable restraint in the Global Blood Group Typing market is the variability in test results and the challenges associated with ensuring consistent accuracy. Inconsistencies can arise from various factors, including variations in testing methodologies, quality of reagents, and the skill level of operators. Such discrepancies not only compromise patient safety but also undermine the reliability of blood typing procedures. This inconsistency poses a significant barrier to the widespread adoption of blood group typing solutions and services, potentially limiting their growth and acceptance in the healthcare sector in the years to come.
Market Trends of the Global Blood Group Typing Market
The Global Blood Group Typing market is witnessing a significant shift towards molecular typing techniques, moving away from traditional serological methods. Advanced technologies such as PCR and DNA sequencing are gaining popularity for their precision in identifying rare and weak blood group antigens, making them invaluable in complex scenarios like prenatal testing and in patients with multiple transfusions. This transition not only enhances the accuracy of blood typing but also minimizes risks of alloimmunization and transfusion reactions, positioning these molecular methods as critical components for improved patient outcomes. Consequently, this trend is poised to substantially increase revenue generation potential in the blood typing industry throughout the forecast period.